In fact, the impairment of eNOS activity due to ischemic stroke and aging has been implicated in numerous cellular mechanisms involving sphingomyelinase- and ceramide-activated phosphatase 2A or AKT pathways, leading to neuronal injury [4,5]. This evidence concerns the gene NOS3 and ischemic stroke.